Alembic Pharma Executes Shareholders Agreement for Canadian Investment

Alembic Pharmaceuticals Limited has executed a Shareholders' Agreement to invest in a newly incorporated Canadian Corporation, 17989377 Canada Inc. The agreement, made with Difgen Holdings LLC and Mr. Sukhad Juneja, aims to establish a platform for developing, commercializing, distributing, and marketing pharmaceutical products in the Canadian market. Alembic Pharmaceuticals will hold a 45% equity stake in the Canadian Corporation, with Difgen Holdings LLC also holding 45% and others holding 10%. The Canadian Corporation will become an associate of Alembic Pharmaceuticals post-investment. The transaction is not considered a related party transaction and is conducted at arm's length.